Hillview Capital Advisors, LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Hillview Capital Advisors, LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$23,000
-39.5%
19,6100.0%0.12%
-39.1%
Q1 2019$38,000
-15.6%
19,6100.0%0.20%
-25.5%
Q4 2018$45,000
-66.4%
19,6100.0%0.27%
-47.7%
Q3 2018$134,000–19,610–0.52%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q1 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders